The use of T-cells with chimeric antigen receptor (CAR-T) in combination with chemotherapy and radiotherapy for the treatment of solid tumors
The introduction of chimeric antigen receptor (CAR) T-cell therapy has revolutionized the treatment of hematological diseases, particularly in combating blood cancer. The success of this cell therapy approach has led to the development of approximately seven commercial CAR-T based drugs. However, th...
Saved in:
| Main Authors: | M. R. Khaliulin, R. N. Safin, M. A. Kunst, E. R. Bulatov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2024-04-01
|
| Series: | Успехи молекулярной онкологии |
| Subjects: | |
| Online Access: | https://umo.abvpress.ru/jour/article/view/647 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adoptitive immunotherapy with genetically engineered T lymphocytes modified to express chimeric antigen receptors
by: A. А. Pavlova, et al.
Published: (2017-04-01) -
Preparation of Trop2-targeted chimeric antigen receptor T cells and study of their exhaustion status in vitro
by: LIU Xiuying, et al.
Published: (2025-08-01) -
Can chimeric antigen receptors – based therapy bring a gleam of hope for thyroid-associated ophthalmopathy and other autoimmune diseases?
by: Zhou Weiyi, et al.
Published: (2025-04-01) -
Advancements and challenges in CAR-T cell therapy for solid tumors: A comprehensive review of antigen targets, strategies, and future directions
by: Jiajun Zhu, et al.
Published: (2025-08-01) -
IL-7 armed binary CAR T cell strategy to augment potency against solid tumors
by: Alejandro G. Torres Chavez, et al.
Published: (2025-07-01)